Food and Drug Administration

Joint Meeting of the
Psychopharmacologic Drugs Advisory Committee
and
Pediatric Advisory Committee

September 13 - 14, 2004

Additional Briefing Information

Food and Drug Administration Background Information

• August 20, 2004 letter to to Psychopharmacologic Drugs Advisory Committee Members/Consultants and Pediatric Advisory Committee Consultants from Anuja M. Patel, MPH, Center for Drug Evaluation and Research, FDA pdf
  
• Table of Contents of Addendum htm
  
• Product Labeling for Prozac (fluoxetine hydrochloride) htm
  
• Product Labeling for Zoloft (sertraline hydrochloride) Tablets and Oral Concentrate pdf
  
• August 20, 2004 FDA Talk Paper; FDA Updates Its Review of Antidepressant Drugs in Children htm